Cardiovascular Diseases Clinical Trial
Official title:
10-year Risk Prediction Models of Complications and Mortality of Diabetes Mellitus in Chinese Patients in Primary Care in Hong Kong
Diabetes Mellitus (DM) is a well-recognized public health issue worldwide. DM can lead to
many complications resulting in morbidity and mortality, approximately 70% of DM related
deaths were attributed to cardiovascular diseases (CVD).
Objectives:
To develop 10-year risk prediction models for CVD, end stage renal disease (ESRD) and
all-cause mortality among Chinese patients with DM in primary care.
Hypotheses:
1. Patient socio-demographic, clinical parameters, disease characteristics and treatment
modalities are predictive of 10-year risk of CVD, ESRD and all-cause mortality.
2. Risk prediction models developed from this study should have over 70% of discriminating
power.
Design and Subjects:
10-year retrospective cohort study. All Chinese patients who were clinically diagnosed to
have DM and were receiving care in the public (Hospital Authority) primary care clinics on or
before 1 July 2006 will be followed up until 31 December 2016.
Main outcomes measures:
For total CVD, CHD, stroke, heart failure, ESRD, all-cause mortality
1. 10-year incidence;
2. Predictive factors
Data analysis:
Two thirds of subjects will be randomly selected as the training sample for model
development. Cox regressions will be used to develop sex-specific 10-year risk prediction
models for each outcome. The validity of models will be tested on the remaining one third of
subjects by Harrell C statistics and ROC
Expected results:
Risk prediction models will enable accurate risk stratification and cost-effective
interventions for Chinese DM patients in primary care.
This study aims to develop 10-year risk prediction models for total CVD and all-cause
mortality among Chinese diabetic patients in primary care. Risk prediction models for
individual DM complications including CHD, heart failure, stroke and ESRD will also be
developed.
The objectives are to:
1. Calculate the 10 years incidence of total CVD, all-cause mortality and each major DM
complication in Chinese DM patients in primary care.
2. Determine the risk factors that significantly predict total CVD, all-cause mortality and
each major DM complication for Chinese DM patients in primary care.
3. Develop and validate risk prediction models for total CVD, all-cause mortality and each
major DM complication for Chinese DM patients in primary care.
4. Develop a risk prediction nomogram and chart for the risk of total CVD, all-cause
mortality for Chinese DM patients in primary care
Hypotheses:
1. Patient socio-demographic, clinical parameters, disease characteristics, and treatment
modalities are predictive of 10-year risk of total CVD, all-cause mortality and
individual DM complication as a dependent variable.
2. The risk prediction models for total CVD, all-cause mortality and individual DM
complication developed in this study can have over 70% of discriminating power.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|